Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

iddleBrook believes that its current funds, together with expected Keflex product sales, will be sufficient to support its currently planned operations through the Company's PDUFA action date of January 23, 2008. These 2007 estimates are forward-looking statements that involve risks and uncertainties, and actual results could vary materially.

CONFERENCE CALL

The Company has scheduled a conference call for today, Wednesday, November 14, 2007 at 10:30 AM ET. During the call, Dr. Edward Rudnic, president and CEO, and Robert Low, vice president, finance and CFO, will discuss quarterly results and other corporate activities. Investors can call 1-800-813-8504 (domestic) and 1-706-643-7752 (international) prior to the 10:30 AM start time and ask for the MiddleBrook Pharmaceuticals conference call hosted by Dr. Rudnic. A replay of the call will be available on November 14, 2007 beginning at 12:30 PM ET and will be accessible until Wednesday, November 21, 2007 at 5:00 PM ET. The replay call-in number is 1-800-642-1687 for domestic callers and 1-706-645-9291 for international callers. The access number is 23072308.

The conference call will also be broadcast simultaneously on the Company's website, http://www.middlebrookpharma.com. Investors should click on the Investor Relations tab and are advised to go to the website at least 15 minutes early to register, download, and install any necessary audio software. The call will also be archived on the MiddleBrook website.

About Middlebrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK, formerly Advancis Pharmaceutical Corporation) is a pharmaceutical company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing a portfolio of anti-infective drugs based on its novel biological finding that
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... NE (PRWEB) , ... July 07, 2015 , ... ... center for MRI services, is debuting their brand new website. The website’s goal ... technology and a wider selection of patient tools, including requesting appointments online. , ...
(Date:7/7/2015)... Washington (PRWEB) , ... July ... ... San Francisco-based Hope Consulting announced today that the two firms have merged ... in the social, health and biopharma sectors. The merger combines SwitchPoint’s strategy ...
(Date:7/7/2015)... York, NY (PRWEB) , ... July 07, 2015 , ... ... the email newsletter and website that helps active people find the most fun activities ... and active lifestyle coverage for millennials. It also increases Greatist’s opportunity for events, e-commerce, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Quadrino Law Group is pleased to announce the ... York 11747. The new facility is a state of the art building, located ... Quadrino, the firm's CEO and founder, said, "We are pleased to service our clients ...
(Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading audit, tax, and ... back to the community through company-wide volunteering efforts. , On an annual basis, in ... to assisting those in need throughout Baltimore and Washington D.C. , This ...
Breaking Medicine News(10 mins):Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:SC&H Group Celebrates 9th Annual Day of Service 2
... 4 (HealthDay News) -- Really, really liking yourself may ... a new study suggests. That,s because narcissists, known ... to talk about and promote themselves, which projects confidence ... In their two-part study, narcissists scored much higher ...
... been sexually abused are five times more likely to cause ... to University of British Columbia research. Sexually abused boys are ... and twice as likely to engage in unprotected sex. ... Health ,s June issue, the UBC study explores links between ...
... patients with non-small cell lung cancer for both mutations and ... to predict response to treatment with antifolates, according to the ... Annual Meeting 2012, held here March 31 - April 4. ... gene mutations have a worse prognosis and do not respond ...
... with an initial phase of delirious struggle before ... one,s surroundings. Scientists now know why this may ... techniques in healthy volunteers, a team of scientists ... the University of Turku, Turku, Finland in collaboration ...
... News) -- A new study finds that preteen girls ... experience side effects after receiving the human papillomavirus (HPV) vaccine, ... are similar to those associated with other vaccines. U.S. ... to 26, within two weeks after they received the Gardasil ...
... Steven Reinberg HealthDay Reporter , TUESDAY, April ... may be at a small risk of an eye ... These commonly prescribed antibiotics, used to fight a variety ... eye problems, including corneal perforations, optic neuropathy and retinal ...
Cached Medicine News:Health News:Narcissists Often Ace Job Interviews, Study Finds 2Health News:Sexually abused boys at risk for more unsafe sex: UBC research 2Health News:KRAS gene mutation and amplification status affects sensitivity to antifolate therapy 2Health News:Scientists solving the mystery of human consciousness 2Health News:Scientists solving the mystery of human consciousness 3Health News:Preteens More Likely to Report HPV Vaccine Side Effects 2Health News:Antibiotics Linked to Retinal Detachment Risk 2Health News:Antibiotics Linked to Retinal Detachment Risk 3
(Date:7/7/2015)... and BANGALORE , July 7, 2015 ... technology provider of innovative clinical trial data management solutions, ... Research Reports) recent publication named " EDC and eCOA ... ". ISR Reports is one of the leading providers ... this report evaluated 22 EDC and eCOA / ePRO ...
(Date:7/7/2015)... EnteroMedics Inc. (NASDAQ: ETRM ), a ... to treat obesity, metabolic diseases, and other gastrointestinal disorders, ... 32,000,000 units. Each unit consists of one share of ... one share of common stock at a purchase price ... in the offering would result in them beneficially owning ...
(Date:7/7/2015)... , July 7, 2015  Monopar Therapeutics LLC, ... compounds, announced that its co-founder and CEO, Chandler ... Council,s Education U.K. Alumni Entrepreneurial Award. The British Council ... , India , and ... outstanding achievements made by entrepreneurs who have leveraged their ...
Breaking Medicine Technology:Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... , , ... Orphan Drug Designation , SILVER SPRING, Md., Dec. 23 ... more transparent and accessible, the FDA has scheduled a series of ... unfamiliar with the process. The FDA can grant a special status, ...
... , , PHILADELPHIA, Dec. 23 URL Pharma today announced ... initiative designed to save patients money on their health insurance co-payment ... no more than $25 for a Colcrys prescription, which equates to ... the prevention and treatment of gout flares and for the treatment ...
Cached Medicine Technology:FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010 2URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 2URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 3URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: